Related Experiment Video
Updated: Jul 6, 2026

Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System
Published on: October 22, 2020
Maternal cigarette smoking, metabolic gene polymorphisms, and preterm delivery: new insights on GxE interactions and
Hui-Ju Tsai1, Xin Liu, Karen Mestan
1Mary Ann and J. Milburn Smith Child Health Research Program, Children's Memorial Hospital and Children's Memorial Research Center, Department of Pediatrics, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. htsai@childrensmemorial.org
Insights
Maternal smoking combined with specific genetic variations in CYP1A1 and GSTT1 significantly elevates the risk of preterm delivery (PTD). This combined effect is particularly pronounced in spontaneous PTD and cases with histologic chorioamnionitis.
Area of Science:
- Genetics and Epigenetics
- Reproductive Health
- Public Health
Background:
- Preterm delivery (PTD) is a major global health concern.
- Maternal smoking and specific gene polymorphisms are known risk factors for adverse pregnancy outcomes.
- Previous research indicated a synergistic effect of smoking and gene variants on low birth weight.
Purpose of the Study:
- To investigate the combined effects of maternal smoking and CYP1A1 MspI/GSTT1 gene polymorphisms on preterm delivery.
- To analyze these associations in the overall PTD population and specific preterm subgroups.
- To explore potential ethnic variations in these relationships.
Main Methods:
- A case-control study involving 1,749 multi-ethnic mothers.
- Regression analyses were used to assess individual and joint associations.
- Covariates were adjusted for in the statistical models.
Main Results:
- Maternal smoking showed a moderate association with PTD (OR = 1.6).
- A significant joint association was found between maternal smoking and high-risk CYP1A1/GSTT1 genotypes with PTD (OR = 5.8).
- This joint effect was strongest in spontaneous PTD, PTD < 32 weeks, and PTD with histologic chorioamnionitis.
Conclusions:
- Maternal smoking significantly increases PTD risk in women with high-risk CYP1A1 and GSTT1 genotypes.
- The synergistic effect of smoking and these genotypes is most pronounced in PTD cases with histologic chorioamnionitis.
- These findings highlight the importance of genetic susceptibility in mediating the impact of smoking on preterm birth.
Abstract:
Preterm delivery (PTD, <37 weeks of gestation) is a significant clinical and public health problem. Previously, we reported that maternal smoking and metabolic gene polymorphisms of CYP1A1 MspI and GSTT1 synergistically increase the risk of low birth weight. This study investigates the relationship between maternal smoking and metabolic gene polymorphisms of CYP1A1 MspI and GSTT1 with preterm delivery (PTD) as a whole and preterm subgroups. This case-control study included 1,749 multi-ethnic mothers (571 with PTD and 1,178 controls) enrolled at Boston Medical Center. After adjusting covariates, regression analyses were performed to identify individual and joint associations of maternal smoking, two functional variants of CYP1A1 and GSTT1 with PTD. We observed a moderate effect of maternal smoking on PTD (OR = 1.6; 95% CI: 1.1-2.2). We found that compared to non-smoking mothers with low-risk genotypes, there was a significant joint association of maternal smoking, CYP1A1 (Aa/aa) and GSTT1 (absent) genotypes with gestational age (beta = -3.37; SE = 0.86; P = 9 x 10(-5)) and with PTD (OR = 5.8; 95% CI: 2.0-21.1), respectively. Such joint association was particularly strong in certain preterm subgroups, including spontaneous PTD (OR = 8.3; 95% CI: 2.7-30.6), PTD < 32 weeks (OR = 11.1; 95% CI: 2.9-47.7), and PTD accompanied by histologic chorioamnionitis (OR = 15.6; 95% CI: 4.1-76.7). Similar patterns were observed across ethnic groups. Taken together, maternal smoking significantly increased the risk of PTD among women with high-risk CYP1A1 and GSTT1 genotypes. Such joint associations were strongest among PTD accompanied by histologic chorioamnionitis.
Related Concept Videos
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Pharmacogenomics: Identification of New Drug Targets
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Pharmacogenetics of Drug Metabolism: Overview
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Animal Mitochondrial Genetics